Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Law Firms
Life Sciences
High-Tech
Competitor Tech Research
Design Risk Screening
Telecom SEP Claim Chart
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report A 2026 patent and literature landscape of wearable continuous health monitoring: key technology clusters, top assignees, emerging directions, and strategic implications.
Article | Report Capivasertib (AZD5363) targets the PI3K/AKT/PTEN pathway in HR+/HER2- breast cancer. Explore the CAPItello-291 Phase III rationale, IP signals, and combination strategy.
Article | Report An overview of tarlatamab's DLL3-targeting BiTE mechanism, the DeLLphi-312 first-line SCLC trial design, and IO + bispecific combination rationale for extensive-stage SCLC.
Article | Report Patritumab deruxtecan (HER3-DXd) is reshaping post-EGFR TKI NSCLC treatment. Explore the patent race, clinical data, and Daiichi Sankyo/AstraZeneca strategy.
Article | Report Explore the 2026 wearable continuous health monitor technology landscape: key patent trends, R&D signals, and innovation intelligence from PatSnap Eureka.
Article | Report LAG-3 combination therapy relatlimab plus nivolumab vs. pembrolizumab in adjuvant melanoma: checkpoint mechanisms, clinical context, and IP landscape analysis.
Article | Report TERN-501 is a selective THRβ agonist developed by Terns Pharmaceuticals for MASH. Explore its patent landscape, mechanism, and competitive positioning against resmetirom.
Article | Report Icotrokinra (JNJ-2113) is the first oral IL-23 receptor peptide inhibitor in Phase III for psoriasis. Explore J&J's patent strategy and the race to challenge injectable biologics.
Article | Report Iptacopan vs. ravulizumab in PNH: how oral Factor B inhibition reshapes complement therapy, hemoglobin endpoints, and the competitive landscape.
Article | Report How GSK depemokimab and tezepelumab are reshaping severe asthma treatment beyond eosinophil-high phenotypes — a deep dive into the alarmin axis competitive race.
Article | Report How amivantamab redefined EGFR exon 20 insertion NSCLC treatment — and why the HER2 pipeline is racing to replicate that blueprint. Patent and clinical data analysis.
Article | Report How luspatercept's ActRIIB ligand trap and BMS's emerging RSK3 inhibitors are redefining anemia treatment in lower-risk MDS and beta-thalassemia beyond transfusion dependence.
Article | Report How AI-based optical emission spectroscopy improves real-time process control in plasma etching — what semiconductor fabs need to know before the data is in.
Article | Report Next-generation GLP-2 analogs are reshaping short bowel syndrome treatment beyond teduglutide. Explore the patent pipeline, key players, and what comes next.
Article | Report How engineers manage version control and traceability for safety-critical embedded software under IEC 62443 — key standards, lifecycle approaches, and toolchain best practices.